🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral sema empty stomach requirement — how strict is it really?

Oral sema empty stomach requirement — how strict is it really?

mike_nyc Sat, May 23, 2026 at 7:04 AM 23 replies 496 viewsPage 1 of 5
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
May 23, 2026 at 7:04 AM#1

I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

What I actually want to know is whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong.

Practical detail welcome, however dull — the duller the better.

47 17maya_sedona, stefan_berlin, Dr.EM_Chicago and 44 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
May 23, 2026 at 7:41 AM#2

Short answer first, then the reasoning. Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.

That is the short version; the long version is somebody else's post.

46 16kim_atl_prep, sarah_TO, wendy_avl and 43 others
Reply Quote Save Share Report
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
May 23, 2026 at 8:17 AM#3
Dr.SleepRoch said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

Agreeing with Dr.SleepRoch, and the qualification matters more than the agreement. The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest. Where it bites is in the first fortnight, when people conclude the tablet does nothing.

Last edited: May 23, 2026 at 1:17 PM
45 15alex_tucson, kevin_tulsa, Dr.PainCLE and 42 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
May 23, 2026 at 8:54 AM#4
mike_nyc said:
I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

Same position here, arrived at the long way round. The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to get there because almost none of the tablet is absorbed. The dose numbers are not comparable across routes and quoting them side by side confuses people.

44 14lucas_SP_BR, lisa_labSD, adam_van and 41 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
May 23, 2026 at 12:25 PM#5

Adding the clinical framing, because it changes how the question reads. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Last edited: May 23, 2026 at 1:25 PM
43 13lucas_SP_BR, lisa_labSD, adam_van and 40 others
Reply Quote Save Share Report
1235

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register